.Sanofi has quit a period 2 ordeal of Denali Therapeutics-partnered oditrasertib in several sclerosi...
.Turnstone Biologics is decreasing its own head count through 60% as well as shaking up its own C-su...
.In a year that has observed an authorization and a range of readouts for metabolic dysfunction-asso...
.Alaunos Rehabs is actually axing a deal with Precigen, giving up licensing rights to an individuali...
.Capricor Therapies is actually taking a triumph lap for their stage 2 Duchenne muscle dystrophy (DM...
.The FDA has put Kezar Life Sciences' lupus test on hold after the biotech warned 4 fatalities durin...
.A period 3 trial of Scholar Stone's back muscular atrophy (SMA) prospect has hit its major endpoint...
.RNA biotech CAMP4 Therapeutics has marked out think about a $67 million IPO, with inflammation-focu...
.A year after the breakdown of an idiopathic pulmonary fibrosis prospect delivered Galecto on a look...
.Taking the floor covering is actually Judo Biography, a promising biotech armed along with $one hun...